Latest / Annapolis News Today | 2 Min News | The Daily News Now!
FDA Approves New Pancreatic Cancer Pill | Annapolis News
FDA just approved a groundbreaking daily pill, Rasonque, for adults with advanced pancreatic cancer — a disease that’s historically been nearly impossible to treat. Targeting the RAS protein that fuels tumor growth, this drug gave patients an average survival of 13.2 months — more than double the 6.7 months seen with standard chemo. With 67,000 new cases annually in the U.S., this approval offers new hope for those who’ve exhausted other options. The FDA fast-tracked it, delivering it six months early, and even let some patients access it before full approval. Side effects like rash…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.